If “Science has a really serious marketing problem” as Larry Page observed, then life extension technologies face even bigger marketing problems. I am definitely not a marketing expert but realized the problem early on when thinking about the lag-phase period of a robust life extension technology. So I made a short email interview with Dave… Continue reading The marketing problem of life extension technologies
Category: Cambridge
Unpublished SENS3 conference report for mainstream scientists!
Recently I wrote a meeting report on the SENS3 conference for a very prestigious science journal, but finally it did not go through the filters. I knew that the chance for publication is small as the journal rarely publish such meeting reports and as it was in many respects an unconventional science conference. The standards… Continue reading Unpublished SENS3 conference report for mainstream scientists!
The first stem cell related Nobel prize: Martin Evans, 2007
The Nobel Assembly at Karolinska Institute has today decided to award The Nobel Prize in Physiology or Medicine for 2007 jointly to Mario R. Capecchi, Martin J. Evans and Oliver Smithies for their discoveries of “principles for introducing specific gene modifications in mice by the use of embryonic stem cells” Link It’s rather a 2/3… Continue reading The first stem cell related Nobel prize: Martin Evans, 2007
SENS3: The stem cell marketplace by Linda Powers, Tucan Capital (slides)
Linda Powers is the managing director and co-founder of Toucan Capital Corp, a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments (the fund markets itself as the The Leading US Investor in Stem Cells and Regenerative Medicine). Out of here insights and facts presented on the… Continue reading SENS3: The stem cell marketplace by Linda Powers, Tucan Capital (slides)
SENS3 conference photo with some unidentified participants
Source and list are on the SENS3 website.
SENS3: Rutledge Ellis-Behnke on a quick nano hemostatic agent
Rutledge Ellis-Behnke from M.I.T. talked on “a nano hemostatic agent that immediately stops bleeding. Hemostasis is a major problem after trauma and during surgery; as much as 50% of surgical time can be spent packing wounds to reduce or control bleeding and there are few effective methods to stop it without causing secondary damage. We… Continue reading SENS3: Rutledge Ellis-Behnke on a quick nano hemostatic agent
Michael Rose, evolutionary SENS and aging as a loss of adaptation (slides)
Embedded on the slideshow below 9 slides of Michael Rose‘s presentation called Slowing and then stopping aging on the SENS3 conference on the 9th of September. (Photos made by me with the iPhone.) Rose’s argument was: Aubrey de Grey’s original SENS proposal is based on the non-evolutionary assumption that aging is a process of accumulating… Continue reading Michael Rose, evolutionary SENS and aging as a loss of adaptation (slides)
Ray Kurzweil’s distance talk on SENS3
Well, I’ve lost the first part of this MacBook made iSight video as I used the iMovie file’s backup version on my Windows partition but out of this segment of the talk you can form some idea on what was going on during Kurzweil’s talk. The distance talk was orchestrated from a little Sony laptop… Continue reading Ray Kurzweil’s distance talk on SENS3
SENS3: English lesson, poster session
No komment.
SENS3: scaling up the human immune system
Arne Akbar had this surprising slide illustrating how powerful and flexible the immune system is in terms of cellular numbers:
Back to Cambridge
I am off to Cambridge to the SENS3 conference. The New Orleans – Washington – Heathrow London – Cambridge trip is about 16 hours from house to house. I’ll be based at Pembroke College. The picture was made by Anna last year in Cambridge at the steps of the old Cavendish Laboratory Building on Free… Continue reading Back to Cambridge
Meet the nodes, “clustered hubs” and links of clathrin-mediated endocytosis
Network biology is a way to integrate fragmented benchwork data in order to understand complex biological phenomena. In a recent Nature paper, entitled Integrating molecular and network biology to decode endocytosis Cambridge (UK) researchers authors Eva Schmid and Harvey McMahon of MRC, Cambridge give a good example of a predictive and experimentally useful systems biology… Continue reading Meet the nodes, “clustered hubs” and links of clathrin-mediated endocytosis
Going to another unconventional science meeting: SENS3, Cambridge, UK
I am visiting the third Strategies for Engineered Negligible Senescence (SENS3) conference, which will be held from 6-10 September 2007 at Queens’ College, Cambridge. Aubrey de Grey (with whom I made a blogterview in 2006), the main organizer and soul behind the conference is clear about the purpose: “The purpose of the SENS conference series,… Continue reading Going to another unconventional science meeting: SENS3, Cambridge, UK
The Cambridge Biotech Cluster: a slide
Here is one slide from my presentation yesterday introducing the merits of Cambridge, UK from a biological, biotechnological point of view:
Goodbye Cambridge! Hello Budapest!
I am in Budapest again from December 23. The Cambridge months were extremely useful from a scientific point of view. (You can hunt down my 2 AA batteries on the photo)
Best talk at Cambridge today, Austin Smith: self-renewal is default
Is is easy to realize on a conference when you are hearing a good talk. The audience starts to take notes and gets focused. That happened today during Austin Smith‘s talk (look at Day 1 picture). Straightforward, not overcomplicated line of thought presented by easily conceivable, step by step slides, and hardcore science (facts). These… Continue reading Best talk at Cambridge today, Austin Smith: self-renewal is default
Cambridge Embryonic Stem Cell Symposium, Day 1
Wow, the promo materials are extremely good (background: my favourite logical towel) And when people are watching….speakers (like here Austin Smith, the leader of the Wellcome Trust Center for Stem Cell Research) try to say interesting things… Best talk point goes to Allan Bradley, Martin Evans‘ disciple – in science these genealogical tales really matter… Continue reading Cambridge Embryonic Stem Cell Symposium, Day 1
Cambridge Embryonic Stem Cell Symposium promoted by Nature
18-19, December, Babbage Lecture Theatre, Cambridge: Opening Symposium including “A celebration of 25 years of embryonic stem cell research in Cambridge” From the intro: In 1981 two papers appeared that reported the derivation of pluripotent stem cell lines from cultured mouse embryos (1, 2). Now called embryonic stem (ES) cells, they have since transformed research… Continue reading Cambridge Embryonic Stem Cell Symposium promoted by Nature
Mobile Pimm
Yesterday I was at the Eagle by accident with András and Krisztián, and a Cold Guinness, an Abbot Ale (Aubrey‘s favourite), an Old Speckled Hen… Then suddenly my iSight saw this:
The image of science: Google-like Biomedical Image Search Engine for pros
Check out the brand new BioMed Search, it is fantastic, currently over 1 million images have been indexed from peer-review journals in biomedical fields and more is on its way. BioMed Search has been created by Alex Ksikes, currently a Ph.D. candidate in Computer Science with focus in Computational Learning Theory at the University of… Continue reading The image of science: Google-like Biomedical Image Search Engine for pros
Be fast, discover: the Watson-Crick paradigm (weekend session)
I tried to explain to my girlfriend the historical recipe of discovering the structure of DNA by Watson and Crick in 3 shots. Place: in front of the blue paque outside Eagle Pub near old Cavendish, Cambridge, UK. (For me, iMovie is not as intuitive without the Help, which explains the poor quality.) From the… Continue reading Be fast, discover: the Watson-Crick paradigm (weekend session)
Mark Hamalainen, the MitoSENS fellow: blogterview on life extension
Mark Hamalainen is a young PhD student at Cambridge University at the mitochondrion lab of Ian Holt. Mark received a Bachelor of Science Honours degree in biochemistry and computing from Queen’s University in Kingston, Ontario. He also had research training as a visiting scholar at the California Institute of Technology and the Biodesign Institute at… Continue reading Mark Hamalainen, the MitoSENS fellow: blogterview on life extension
Blogterview with Aubrey de Grey: life extension stories
Aubrey de Grey is the man, who first made serious, scientifically conceptualized life extension speech acceptable within scholarly circles through good timing, well-done strategy and with a little bit of luck. The rest is … (I’ve slightly modified the original question 4 and separated questions concerning the probable technologies of moderate and maximum life extension.)… Continue reading Blogterview with Aubrey de Grey: life extension stories
Pimm in Cambridge
I have just arrived in Cambridge to work in an established stem cell lab from October till December. It is a tremendous opportunity for a rookie researcher. That means I’ll be doing experiments heavily, acquire new methods and hopefully work on my favourite puzzle topic yet. Oh, I almost forgot: this is old U.K. Cambridge,… Continue reading Pimm in Cambridge